Traveka Wealth, LLC Novo Nordisk A S Transaction History
Traveka Wealth, LLC
- $197 Billion
- Q3 2024
A detailed history of Traveka Wealth, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Traveka Wealth, LLC holds 8,552 shares of NVO stock, worth $920,451. This represents 0.52% of its overall portfolio holdings.
Number of Shares
8,552
Previous 8,635
0.96%
Holding current value
$920,451
Previous $1.23 Billion
17.38%
% of portfolio
0.52%
Previous 0.6%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,951Shares Held
320MCall Options Held
5.22MPut Options Held
5M-
Jennison Associates LLC21.2MShares$2.28 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.57 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.53 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.44 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.35 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $243B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...